The Jenner Institute is a research partnership between the University of Oxford and The Pirbright Institute.
The Institute focuses on the parallel development of human and vetinary vaccines against major global diseases - from early-stage research through to clinical trials.
Oxford University has been ranked number one in the UK for the quality of its research. The official UK-wide assessment of all university research, the Research Excellence Framework, found that Oxford has the largest volume of world-leading research in the country.
Clinical trials are an essential part of vaccine development, and our volunteers play a critical role in our studies.
If you would like to find out more about paid clinical trials, and what is involved in participating, please go to our Recruiting Trials page to see which trials are currently recruiting.
Prof Charles Phelps, University of Rochester and Dr Guru Madhavan, Institute of Medicine, National Academy of Science: SMART vaccine software - Strategic Multi-Attribute Ranking Tool for Vaccines, 21 Jan 11:00
How does the humoral response to HIV-2 infection differ from HIV-1 and can this explain the distinct natural history of infection with these two human retroviruses? Immunol Lett , 163 (1)
TB vaccine development: where are we and why is it so difficult? Thorax